
Gentian Diagnostics Investor Relations Material
Latest events

Q4 2024
Gentian Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Gentian Diagnostics
Access all reports
Segment Data
Access more data
Sales by
Geography
Europe
Asia
U.S.
Expenses by
Financials
Gentian Diagnostics ASA is a Norwegian company that specializes in the development and production of in-vitro diagnostic (IVD) reagents. The company’s focus is on creating biochemical reagents for use in clinical chemistry analyzers, particularly utilizing Particle-Enhanced Turbidimetric Immunoassays (PETIA). These assays enable faster, automated testing for various medical conditions, improving operational efficiency for clinical labs. Gentian’s products target key areas such as infections, inflammation, kidney disease, cardiac conditions, and veterinary medicine. Gentian Diagnostics is headquartered in Moss, Norway, and its shares are listed on the Oslo Stock Exchange.
Key slides for Gentian Diagnostics


Q4 2024
Gentian Diagnostics


Q4 2024
Gentian Diagnostics
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
GENT
Country
🇳🇴 Norway